Venkata Indurthi, PhD, is the chief scientific officer of Aldevron, a Danaher Life Sciences company that works with CRISPR innovators from early research through clinical use, providing custom nucleases, next-generation plasmid vectors, RNP complexing and analytic services, and more. He has been a member of the Aldevron team since he received his doctorate in pharmaceutical sciences from North Dakota State University, Fargo, ND, in 2016. He has held a variety of positions in increasing responsibility and focus, including senior scientist in product and process design, director of RNA operations, director and then vice president of research and development before being named chief scientific officer in 2022. Indurthi received his Bachelor of Science in Biotechnology from SRM University, Chennai, India, in 2010.